NuCana Plc (NCNA)
2.04
+0.01
(+0.49%)
USD |
NASDAQ |
May 19, 14:37
NuCana Research and Development Expense (Quarterly) : 4.329M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Autolus Therapeutics Plc | 21.17M |
| Mereo BioPharma Group Plc | 4.739M |
| Bicycle Therapeutics Plc | 54.84M |
| DBV Technologies SA | 31.31M |